N4-(3-Chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)quinazoline-4,6-diamine

95%

  • Product Code: 56376
  CAS:    267243-68-5
Molecular Weight: 431.89 g./mol Molecular Formula: C₂₁H₂₃ClFN₅O₂
EC Number: MDL Number: MFCD12032145
Melting Point: Boiling Point:
Density: Storage Condition: room temperature, dry
Product Description: This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research, particularly in the development of targeted cancer therapies. It functions as a potent inhibitor of specific tyrosine kinases, which are enzymes involved in signaling pathways that promote cancer cell growth and survival. By blocking these enzymes, the compound helps to halt the proliferation of cancer cells and can induce apoptosis, or programmed cell death. Its application is especially relevant in the treatment of various cancers, including lung, breast, and colorectal cancers, where abnormal kinase activity is a contributing factor. Researchers also explore its potential in combination therapies to enhance efficacy and overcome drug resistance in cancer treatment. Additionally, its structural features make it a valuable candidate for further optimization in drug discovery processes aimed at improving selectivity and reducing side effects.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.025 10-20 days $184.83
+
-
0.100 10-20 days $446.51
+
-
N4-(3-Chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)quinazoline-4,6-diamine
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research, particularly in the development of targeted cancer therapies. It functions as a potent inhibitor of specific tyrosine kinases, which are enzymes involved in signaling pathways that promote cancer cell growth and survival. By blocking these enzymes, the compound helps to halt the proliferation of cancer cells and can induce apoptosis, or programmed cell death. Its application is especially relevant in the treatment of various cancers, including lung, breast, and colorectal cancers, where abnormal kinase activity is a contributing factor. Researchers also explore its potential in combination therapies to enhance efficacy and overcome drug resistance in cancer treatment. Additionally, its structural features make it a valuable candidate for further optimization in drug discovery processes aimed at improving selectivity and reducing side effects.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: $0.00
$0.00 Total :